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Abstract 
Background: Patients are at risk of deterioration on discharge from an emergency department (ED) to a ward, par-
ticularly in the first 72 h. The implementation of a structured emergency nursing framework (HIRAID) in regional New 
South Wales (NSW), Australia, resulted in a 50% reduction of clinical deterioration related to emergency nursing care. 
To date the cost implications of this are unknown. The aim of this study was to determine any net financial benefits 
arising from the implementation of the HIRAID emergency nursing framework.
Methods: This retrospective cohort study was conducted between March 2018 and February 2019 across two hospi-
tals in regional NSW, Australia. Costs associated with the implementation of HIRAID at the study sites were calculated 
using an estimate of initial HIRAID implementation costs (AUD) ($492,917) and ongoing HIRAID implementation costs 
($134,077). Equivalent savings per annum (i.e. in less patient deterioration) were calculated using projected estimates 
of ED admission and patient deterioration episodes via OLS regression with confidence intervals for incremental addi-
tional deterioration costs per episode used as the basis for scenario analysis.
Results: The HIRAID-equivalent savings per annum exceed the costs of implementation under all scenarios (Conserv-
ative, Expected and Optimistic). The estimated preliminary savings to the study sites per annum was $1,914,252 with a 
payback period of 75 days. Conservative projections estimated a net benefit of $1,813,760 per annum by 2022–23. The 
state-wide projected equivalent savings benefits of HIRAID equalled $227,585,008 per annum, by 2022–23.
Conclusions: The implementation of HIRAID reduced costs associated with resources consumed from patient 
deterioration episodes. The HIRAID-equivalent savings per annum to the hospital exceed the costs of implementation 
across a range of scenarios, and upscaling would result in significant patient and cost benefit.
Keywords: Emergency nursing, Emergency department, Framework, Cost benefit, Patient safety, patient 
deterioration
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco 
mmons. org/ publi cdoma in/ zero/1. 0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background
In-hospital adverse events are associated with increased 
mortality, morbidity and treatment costs [1] and the 
incidence of them in emergency admission patients is 
more than double that of non-emergency patient admis-
sions [2]. Australia’s 292 Emergency Departments (EDs) 
treated more than 8.2 million patients in 2019–20 [3]. ED 
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patients generally have undiagnosed conditions and vary-
ing degrees of clinical urgency and severity [4].
When patients attend an ED, emergency nurses are the 
first health care provider to assess the patient and com-
mence emergency care, so patient safety is contingent on 
their accurate assessment, interpretation of clinical data, 
intervention, early recognition of deterioration and esca-
lation of care [5, 6]. Failure to recognise and respond to 
clinical deterioration during emergency care increases 
the incidence of high-mortality adverse events both dur-
ing emergency care but also following the emergency 
care episode, irrespective of whether the patient is admit-
ted to hospital or discharged [7, 8].
Clinical deterioration within 72 h of admission via the 
ED is an adverse event and can be associated with the 
care in ED [7, 8]. Patients admitted via the ED and who 
deteriorate on the ward during the early stage of their 
admission also have significantly higher in-hospital mor-
tality [7, 9]. In our health district, the average (SD) treat-
ment costs for patients who deteriorated within 72 h of 
hospital admission via the ED were tripled, irrespective 
of diagnosis, age or hospital length of stay (LOS) [10].
Health care organisations outlay significant funds for 
nurse education, education staff and online mandatory 
training, yet evaluations that yield information about 
the return on investment are scarce, particularly in rela-
tion to patient safety or health service outcomes [11]. 
The existing evidence base does not enable any empiri-
cal conclusions to be drawn about the economic value 
of continuing health professional development [12]. 
This study seeks to examine the outcome of investment 
in an intervention with a considerable nursing educa-
tion component in relation to cost benefit.
Implementation of a nurse-led framework called 
HIRAID (History, Identify Red flags, Assessment, 
Interventions, Diagnostics, communication and reas-
sessment) [13] was developed for emergency care deliv-
ery (Fig.  1) in our Local Health District. The findings 
of this study resulted in a 50% (27 to 13%) reduction of 
inpatient clinical deterioration associated with care in 
the ED as classified by the Human Factors Classifica-
tion Framework for patient safety [14]. HIRAID is the 
only validated framework designed to enable emer-
gency nurses to systematically assess and manage ED 
patients [15]. The cost of HIRAID implementation and 
any cost-benefit is unknown. The aim of this study was 
to determine the financial costs and payback period of 
implementing the HIRAID emergency nursing frame-
work and any potential future net financial benefits as 
a result of decreased inpatient deterioration related to 
ED care.
Fig. 1 The HIRAID Emergency Nursing Framework.© Curtis, Munroe, Murphy, Strachan, Lewis & Buckley 2016, adapted from Curtis et al. 2009
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Methods
Study design and setting
This retrospective cohort study was conducted between 
March 2018 and February 2019 across two hospitals in 
regional NSW, Australia. This study was approved by 
the site health and medical human research ethics com-
mittee (LNR/16/WGONG/249) and conducted per the 
approved protocol.
Implementation of HIRAID
HIRAID was introduced to the EDs using a detailed 
implementation strategy, the development of which is 
reported elsewhere [16]. Modes of delivery selected to 
implement HIRAID included: (i) the development and 
compulsory completion of an eLearning module; (ii) 
attendance at a half day HIRAID workshop; (iii) integra-
tion of HIRAID into ED orientation programs and spe-
cialty training programs; (iv) mandated quarterly random 
audits of 10 episodes of initial nursing documentation at 
all sites; (v) introduction of cues within the workplace 
such as posters and reference cards; development and; 
(vi) mandated use of a documentation template based on 
the HIRAID assessment structure [16]. A template out-
lining the range of HIRAID implementation costs was 
generated. From this list of cost outlays, we determined 
the initial HIRAID implementation cost and ongoing 
annual implementation costs.
Cost of patient deterioration during early stages 
of hospital admission
Similar to the majority of high income countries [17], 
Australia uses diagnostic related groups to calculate 
public hospital funding on an activity basis, specifically, 
Australian Refined Diagnosis Related Groups (AR-DRGs) 
[18]. AR-DRGs group patients with similar diagnoses 
requiring similar hospital services and is updated every 
3 years along with the International Statistical Classifica-
tion of Diseases and Related Health Problems, Austral-
ian Classification of Health Interventions and Australian 
Coding Standards classification (ICD-10-AM/ACHI/
ACS). Episodes of admitted acute care are assigned with 
disease and intervention codes by health information 
managers or clinical coders. AR-DRGs are then assigned 
based on these codes and a number of other routinely 
collected variables including age, sex, mode of separa-
tion, length of stay, newborn admission weight and hours 
of mechanical ventilation [18].
Data on patients experiencing clinical deterioration 
within 72 h of admission were provided to the site cost-
ing unit. Clinical deterioration was defined as a cardiac 
arrest, unplanned intensive care unit admission or a rapid 
response call [19]. Staff can activate a rapid response call 
when they are concerned patient deterioration needs 
immediate medical review by the critical care team. The 
criteria for activation of a rapid response call are stand-
ardised across the NSW State health system [14]. The 
AR-DRGs (v8.0) of these patients were extracted, and 
a cost comparison between those who did and did not 
have a deterioration episode was recorded. The top 10 
AR-DRGs were also compared. Treatment costs included 
direct, indirect and corporate overhead costs. When con-
trolled for confounders (LOS, AR-DRG code and oth-
ers), the average incremental cost of clinical deterioration 
in the first 72 h of hospital admission via the ED was 
$2591.14 (CI +/− $654.92) [19]. These costs were used 
as the basis for the analyses in this study. The currency 
presented is Australian dollar (AUD).
Data analysis
Data were cleaned (validations and definitions) and col-
lated for descriptive analysis. Data were analysed using 
Stata Version 14.2 (StataCorp, College Station, USA) to 
test if the deterioration and non-deterioration patient 
groups were equal in characteristics. T-tests or Mann 
Whitney U tests were used for the comparison of contin-
uous variables. Chi-square tests were used for categori-
cal variables. All statistical tests were conducted as two 
tailed, and a confidence level of 95% was used to deter-
mine if there was a significant association between the 
cohorts and variables of interest. For the cost analyses, 
there were two main calculations within the analysis: i) 
hospital level net benefit figure; and ii) payback period. 
The hospital level net benefit figure was calculated by 
offsetting the cost of savings per episode of clinical dete-
rioration within 72 h of admission via the ED, against 
the initial and ongoing implementation costs per hospi-
tal from the HIRAID initiative. We used the confidence 
intervals from Curtis et  al. (2021) [19] as the basis for 
an optimistic ($2591.14 + $654.92) and conservative case 
($2591.14 - $654.92) for the value of savings per episode 
of deterioration, with the expected case being $2591.14 
itself.
We then multiplied this value by the total expected 
patient deterioration in ED across NSW, estimated by 
taking the deterioration percentage (929 deterioration 
episodes/25,026 total ED admissions for our meas-
ured 352 common AR-DRG categories) in the HIRAID 
test sites [20]. This reflects a 3.7% deterioration pro-
portion. That percentage was multiplied by the total 
projected ED admissions figure, initially obtained for 
2018–19 using the NSW government health data por-
tal [21], with 2% growth estimates conservatively esti-
mated (the prior 7 years revealed an average growth 
rate higher than 2.5%). Multiplying these by the dete-
rioration percentage gave us a deterioration estimate 
projection. The deterioration saving cost (conservative, 
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expected and optimistic) were obtained by multiplying 
the relevant average cost of deterioration savings by the 
deterioration episode estimate, to reveal the state level 
projections. The hospital level savings projections were 
estimated by identifying a per hospital average of 465 
deterioration encounters – obtained by dividing the 
929 deterioration encounters noted in across both ED 
departments where the data were collected [20]. We 
did not factor in a nominal or real inflation rate on the 
rate of increase in pricing to be even more conservative 
with our savings estimates.
The variable formula calculations from the site level 
and state level are as shown below:
Step 1: Variable formula (site/hospital level):
Conservative 1936.22 savings per encounter * Det. 
encounter volume - Initial program 
investment = Net Savings in sample 
sites
Moderate $2591.14 savings per encounter * Det. 
Encounter volume - Initial program 
investment = Net savings in sample 
sites
Optimistic $3246.06 savings per encounter * Det. 
Encounter volume - Initial program 
investment = Net savings in sample 
sites
Step 2: Variable formula (state level for all three scenarios)
Relevant ARDRG ED admissions estimate * Net savings per encounter = Net 
state level savings
The variable definitions relating to the two formulas from Table 3 
above, are explained below:
Step 1 formula (site level)
Savings per encounter: Extracted from Curtis, et al. (2021) with conserva-
tive, moderate and optimisitic savings estimated using the standard 
deviation estimates from the same data.
Deterioration encounter volume at the site level: as extracted from the site 
empirics, per Curtis et al. (2021)
Initial program investment - comprised of initial training, manual and 
staff time related costs associated to the establishment of the program.
Step 2 formula (for all three state scenarios, Conservative, Moder‑
ate and Optimistic)
Relevant ARDRG ED admissions estimate: (Site level relevant ARDRG 
admissions/site level total ED admissions) * state-wide ED admissions
Net savings per encounter: Extracted from Curtis, et al. (2021) with 
conservative, moderate and optimistic savings estimated using the 
standard deviation estimates from the same data.
The payback period estimates how quickly the setup 
costs of an initiative, in this case, the implementation 
of HIRAID is “paid-back” or covered by the equivalent 
value of its benefits generated (reduction in deteriora-
tion). By dividing the implementation cost per annum 
by the equivalent per annum savings estimate and mul-
tiplying the resulting number by 365 days, we generated 
a payback period – an assessment of how quickly the 
HIRAID investment “paid” for itself on an annual basis. 
The Payback period variable formula to express the above 
is as follows: Payback period = (Initial cost outlay/Total 
net savings) * 365 days.
Results
The estimated initial HIRAID implementation cost in 
Year 1 was $492,917, and ongoing implementation costs 
$134,077 per annum (Table 1).
Of the 25,062 patients included in the study 929 
patients experienced an episode of deterioration within 
72 h of admission via the ED (Table  2). Patients who 
deteriorated were significantly older (median 73.4 vs 
67.5 years, p <  0.001) and had a longer median ED length 
of stay (9.0 vs 7.0 h, p <  0.001), LOS (10.48 vs 8.99 days, 
p <   0.001) than patients who did not deteriorate. For 
patients who had an ICU admission, patients who dete-
riorated within 72 h of admission via the ED had sig-
nificantly longer ICU length of stay (3.74 vs 3.18 days, 
p <  0.001) than patients who did not deteriorate.
Hospital net benefit
The hospital level net benefit figure in the first year of 
HIRAID implementation ranged from $1,305,831 (con-
servative) to $2,522,673 (optimistic). The expected ongo-
ing annual hospital net benefit figure was $2,472,610. 
This was calculated by multiplying the cost of savings per 
episode by the 465 average savings encounters per hos-
pital (929 deterioration savings encounters/2 sites), and 
subtracting initial and ongoing implementation costs per 
hospital from this amount, as identified from HIRAID 
site estimates ($492,917 initial, ongoing $134,077 per 
annum). Staff research costs dominated initial year cost-
ings. These would be far less in new hospital sites, but 
we conservatively chose to include them. We showed net 
savings under all scenarios, across all 5 years, even when 
implementation cost concerns were considered (Table 3).
Hospital payback period
For return of investment for the initial implementation 
of HIRAID, the longest hospital payback period was 
100 days (conservative scenario, 2018–19) and the quick-
est (shortest) payback period was 60 days (optimistic sce-
nario, 2018–19). For ongoing investment and sustained 
implementation of HIRAID, the longest hospital pay-
back period was 26 days (conservative scenario, 2018–19) 
and the quickest (shortest) payback period was 15 days 
(optimistic scenario, 2022–23). These are all well under 
a year, meaning the health service re-obtains their invest-
ment via the opportunity cost saving of deterioration 
avoidance.
NSW state‑wide projected savings and payback period
State-wide HIRAID implementation projected savings 
were calculated at $227,585,008 per annum for hospitals 
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Table 2 Patient characteristics, emergency and hospital LOS by deterioration vs no deterioration event within 72 h of admission via ED
Variable No deterioration within 72 h
(n = 24,133)
Deterioration within 72 h
(n = 929)
p‑value
Age – Median (IQR) 67.5 (44.9–80.9) 73.4 (60.8–83.0) <  0.001
Gender – n (%)
 Male 11,518 (47.7) 474 (51.0) 0.048
 Female 12,615 (52.3) 455 (49.0)
ED LOS (h) – Median (IQR) 7.0 (3.9–12.3) 9.0 (5.4–14.4) <  0.001
Site – n (%)
 Site 1 18,488 (76.6) 656 (70.6) <  0.001
 Site 2 5645 (23.4) 273 (29.4)
Time of presentation – n (%)
 Morning (07:00–15:00) 11,166 (46.3) 462 (49.7) 0.116
 Afternoon (15:01–22:00) 8876 (36.8) 319 (34.3)
 Night (22:01–06:59) 4091 (17.0) 148 (15.9)
Time of admission – n (%)
 Morning (07:00–15:00) 7683 (31.8) 282 (30.4) 0.465
 Afternoon (15:01–22:00) 9611 (39.8) 368 (39.6)
 Night (22:01–06:59) 6839 (28.3) 279 (30.0)
Average ED LOS (hours) 8.99 (6.51) 10.48 (6.65) <  0.001
Average hospital LOS (days) 4.54 (5.81) 12.47 (12.41) <  0.001
Average ICU LOS (days)(ICU cases only) 3.18 (4.15) 3.74 (4.82) <  0.001
Table 3 Analysis of savings and net benefits from prevention of clinical deterioration in ward patients during the early stages of 
emergency admission
* Hospital deterioration episode encounter projection is 465, a whole number average per hospital deterioration from the 929 deteriorations observed over the two 
sites (Table 1)
Outcome 2018–19 2019–20 2020–21 2021–22 2022–23
ED admission growth rate 3.34% 2.00% 2.00% 2.00% 2.00%
Projected ED admissions (352 AR-DRG) 2,189,030.929 2,232,811.547 2,277,467.778 2,323,017.134 2,369,477.477
Statewide deterioration episode projection 81,143 82,766 84,421 86,110 87,832
Expected equivalent savings (state level estimates)
Conservative ($1936.22 per episode) $157,110,699 $160,253,185 $163,457,629 $166,727,904 $170,062,075
Expected ($2591.14 per episode) $210,252,873 $214,458,293 $218,746,630 $223,123,065 $227,585,008
Optimistic ($3246.06 per episode) $263,395,047 $268,663,402 $274,035,631 $279,518,227 $285,107,942
Net benefit - hospital level estimates: expected equivalent savings less HIRAID implementation costs:
 Conservative ($1936.22 per episode) $1,798,748 $1,835,537 $1,872,325 $ 1,909,113 $ 1,947,837
Implementation costs (initial and ongoing) -$492,917 -$134,077 -$ 134,077 -$ 134,077 -$ 134,077
 Net savings $ 1,305,831 $1,701,460 $1,738,248 $ 1,775,036 $ 1,813,760
 Payback period days: (Inv. Outlay/Det. Savings) * 365 days 100.02 26.66 26.14 25.63 25.12
 Expected ($2591.14 per episode) $2,407,169 $2,456,401 $2,505,632 $ 2,554,864 $ 2,606,687
Implementation costs (initial and ongoing) -$492,917 -$134,077 -$134,077 -$134,077 -$ 134,077
 Net savings $1,914,252 $2,322,324 $2,371,555 $420,787 $2,472,610
 Payback period days: (Inv. Outlay/Det. Savings) * 365 days 74.74 19.92 19.53 19.15 18.77
 Optimistic ($3246.06 per episode) $3,015,590 $3,077,265 $3,138,940 $3,200,615 $3,265,536
Implementation costs (initial and ongoing) -$492,917 -$134,077 -$134,077 -$134,077 -$134,077
 Net savings $2,522,673 $2,943,188 $ 3,004,863 $3,066,538 $3,131,459
 Payback period days: (Inv. Outlay/Det. Savings) * 365 days 59.66 15.90 15.59 15.29 14.99
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with an ED. The total projected ED admissions fig-
ure with 2% growth estimates conservatively estimated 
yielded the State-wide ED admissions shown in Table 3. 
The spectrum of cost savings possibilities presented sta-
tistically relates to 90% of possible outcomes (optimistic 
being in the top 5 percentile, conservative being in the 
bottom 5 percentile). For each scenario, the statistically 
derived equivalent savings per episode was multiplied 
against the number of deteriorations to calculate a sav-
ings figure.
Discussion
This study determined the initial investment required 
for and net financial benefits arising from the imple-
mentation of the HIRAID emergency nursing 
framework at a hospital and State-wide level. The imple-
mentation of HIRAID resulted in an estimated cost ben-
efit of $1,914,252 to the study sites with a 75-day payback 
period. State-wide implementation of HIRAID could save 
NSW public hospitals $277million per year as a result of 
decreased inpatient deterioration. These findings speak 
strongly in favour of the benefit of HIRAID economically, 
in addition to its clear patient level benefits.
Nurses are by far the largest proportion of the profes-
sional health workforce. Emergency care presentations 
are increasing exponentially around the world and qual-
ity nursing care is fundamental to patient safety [4]. The 
World Health Assembly (WHA) 2019 draft resolution 
recommended emergency care training through special-
ity training programmes [22]. This study demonstrates 
that such an initiative could potential result in financial 
savings to the implementing health care system.
The application of HIRAID is not dependent on con-
text, clinical skill level or resources. The operation-
alisation of HIRAID as a basic assessment process, and 
foundation for nurse-initiated care protocols can be read-
ily adapted for implementation in other international 
jurisdictions [23]. HIRAID train-the-trainer courses have 
been delivered in Sri Lanka, Fiji, Nepal and Colombia. 
However, HIRAID has only been tested in Australia [14, 
16]. HIRAID requires formal consultation with emer-
gency nurses internationally [23].
The implementation of HIRAID required an initial 
investment, particularly to conduct education and train-
ing. This investment was rapidly offset in all three pro-
jected scenarios to 2022–23 All health professional 
education and introduction of interventions within 
ED come with significant costs, which we have explic-
itly described in this study. The importance of planning 
and investment in implementation cannot be under-
stated. There are many instances of less than adequate 
implementation results in the ED setting where clini-
cian behaviour change is difficult to achieve [24–27]. 
Successful implementation needs appropriate funding, 
planning and strategies that address the complexity and 
micro-politics embedded within all health care systems. 
Implementation strategies need to support individual 
practitioners, managers, and understand the context as 
well as receive strong organisational support and patron-
age which is influential to normalising a new practice 
among staff [28]. An evidence informed and context spe-
cific implementation strategy is essential to sustained, 
reliable and high uptake [16, 29]. While education and 
training is accompanied by associated cost, this study has 
shown that HIRAID can lead to significant cost benefits 
and pay back for an organisation. We recommend the 
employment of a HIRAID nurse for 18 months to imple-
ment, embed and monitor uptake that is tailored for each 
ED context.
Prevention and early identification of patient deterio-
ration improves outcomes, quality of life and lessens the 
intervention required to stabilise patients whose condi-
tion deteriorates unexpectedly in acute health service 
organisations [2]. Several health service wide interven-
tions have been implemented to address the multiple 
complex organisational and workforce factors that con-
tribute to patient deterioration [30]. Nonetheless, avoid-
able patient deterioration rates continue as a result of 
failure to recognise and rescue. Across the literature 
recognizing patient deterioration comprises four key 
areas: (1) assessing the patient; (2) knowing the patient; 
(3) education and (4) environmental factors [31]. The 
HIRAID framework [13], and accompanying implemen-
tation strategy [29] encompasses these areas ensuring 
emergency nursing staff have the capability, capacity and 
opportunity to apply HIRAID in their clinical practice.
Future research should include the evaluation of other 
benefits of improved emergency nursing care, nurse sen-
sitive adverse events and patient deterioration. For exam-
ple, the reduced LOS that is generated through reduced 
patient deterioration [14] and nurse sensitive adverse 
events [32] may create additional inpatient capacity. 
This in turn could improve associated key performance 
indicators such as non-compliance with emergency 
treatment performance (ETP), which is an independent 
predictor of all cause 30-day mortality for patients pre-
senting to, and admitted via ED [33].
There are limitations to this study. Although all care 
was taken in the identification and assessment of patient 
deterioration events and a standardised process used, it 
is possible some were missed. Although we examined 
ED care related causal factors to the deterioration event 
[14], we did not collect information on potential ward 
based factors for the event, such as staffing levels. This 
study was conducted in one health district, and despite 
the incidence of patient deterioration and adverse events 
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in all hospitals, the types of incidences may differ, reduc-
ing the applicability to other hospitals. Cost estimates are 
likely to differ between countries, institutions and popu-
lations, thus potentially limiting the generalisability of 
this and all cost-effectiveness studies in health education 
[34].
Conclusions
The implementation of a structured emergency nursing 
framework resulted in substantial cost benefit with pay-
back of investment within a year. The State-wide imple-
mentation of HIRAID could save $227million per year. 
Initial investment in a dedicated senior implementation 
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